Reflections on reconduction after pulmonary vein isolation

Europace

Volumn 11, Issue 4, 2009, Pages 400-401

  Van Belle, Yves ^a   Jordaens, Luc ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BALLOON CATHETER; CARDIOVERSION; CATHETER ABLATION; CRYOBALLOON; EDITORIAL; ENDOSCOPIC THERAPY; ESOPHAGUS FISTULA; FOOD AND DRUG ADMINISTRATION; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HUMAN; INTERMETHOD COMPARISON; LASER; LUNG VEIN; MEDICAL TECHNOLOGY; NERVE INJURY; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PATIENT SAFETY; PHRENIC NERVE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ABLATION TECHNIQUES; ATRIAL FIBRILLATION; CRYOTHERAPY; HUMANS; PULMONARY VEINS; REGIONAL BLOOD FLOW;

EID: 65249113203     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup057     Document Type: Editorial

References (24)

1. Van Belle Y, Janse P, Rivero-Ayerza MJ, Thornton AS, Jessurun ER, Theuns D et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J 2007; 28:2231-7.
2. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008;52:273-8.
3. Van Belle Y, Janse P, Theuns D, Szili-Torok T, Jordaens L. One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace 2008;10:1271-6.
4. Schmidt B, Antz M, Ernst S, Ouyang F, Falk P, Chun JK et al. Pulmonary vein isolation by high-intensity focused ultrasound: first-in-man study with a steerable balloon catheter. Heart Rhythm 2007;4:575-84.
5. Borchert B, Lawrenz T, Hansky B, Stellbrink C. Lethal atrioesophageal fistula after pulmonary vein isolation using high-intensity focused ultrasound (HIFU). Heart Rhythm 2008;5:145-8.
6. Boersma LV, Wijffels MC, Oral H, Wever EF, Morady F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm 2008;5:1635-42.
7. Chierchia GB, de Asmundis C, Müller-Burri S-A, Sarkozy A, Capulzini L et al. Early recovery of pulmonary vein conduction after cryoballoon ablation for paroxysmal atrial fibrillation: a prospective study. Europace 2009;11:445-449.
8. Cappato R, Negroni S, Pecora D, Bentivegna S, Lupo PP, Carolei A et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation 2003;108:1599-1604.
9. Lemola K, Hall B, Cheung P, Good E, Han J, Tamirisa K et al. Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation. Heart Rhythm 2004;1:197-202.
10. Cheema A, Dong J, Dalal D, Marine JE, Henrikson CA, Spragg D et al. Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007;18: 387-91.
11. Arentz T, Macle L, Kalusche D, Hocini M, Jais P, Shah D et al. 'Dormant' pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004;15:1041-7.
12. Spencker S, Coban N, Koch L, Schirdewan A, Müller D. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 2009;11:483-488.
13. Theuns DAMJ, Res JCJ, Jordaens LJ. Home monitoring in ICD therapy: future perspectives. Europace 2003;5:139-42.
14. Jung W, Rillig A, Birkemeyer R, Miljak T, Meyerfeldt U. Advances in remote monitoring of implantable pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems. J Interv Card Electrophysiol 2008;23:73-85.
15. Raatikainen MJP, Uusimaa P, van Ginneken MME, Janssen JPG, Linnaluoto M. Remote monitoring of implantable cardioverter defibrillator patients: a safe, timesaving, and cost-effective means for follow-up. Europace 2008;10:1145-51.
16. Brugada P. What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clin Res Cardiol 2006;95:III/3-III/9.
17. Varma N. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Am Heart J 2007;154:1029-34.
18. Crossley G, Boyle A, Vitense H, Sherfesee L, Mead RH. Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: The Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study. Am Heart J 2008;156:840-6.
19. Muratore CA, Sá LAB, Chiale PA, Eloy R, Tentori MC, Escudero J et al. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America. Europace 2009;11: 164-8.
20. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VA. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 2007;18:1236-40.
21. Leite LR, Fenelon G, Simões A Jr, Silva GG, Friedman PA, de Paola AAV. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol 2003;14:567-73.
22. Cardinalli-Neto A, Greco OT, Bestetti RB. Automatic implantable cardioverter defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol 2006;29: 467-70.
23. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS et al. ACC/AHA/HRS guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 2008;117: e350-408.
24. Exner DV, Klein GJ. Do we need a randomized trial of defibrillator therapy in every subset of patients with increased risk of sudden death? J Cardiovasc Electrophysiol 2003;14:574-7.